STRONG group prenatal care to reduce gestational diabetes in American Samoa
Official title: STRONG: a group prenatal care intervention to reduce gestational diabetes among women in American Samoa
Funded at Yale University · NIH-11465085 · Data updated 2026-11-12
A Yale-led program tests a group prenatal care approach to lower gestational diabetes among pregnant Pacific Islander women in American Samoa.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $867,162 |
| NIH project number | 1R01HD120157-01A1 |
| Project ID | NIH-11465085 on NIH RePORTER |
Who could benefit from this research
✓Could help
Pregnant women in American Samoa at risk for gestational diabetes who participate in group prenatal care.
✕Less likely to help
Some individuals may not respond to the intervention or may prefer standard individual prenatal care.
What this research studies
This project builds on a proven prenatal group program (STRONG) to see if it can reduce the rate of gestational diabetes among pregnant American Samoan women. It plans a fully powered, organized trial to confirm the intervention’s effectiveness and real-world potential. If successful, the approach could become a scalable option to improve maternal health and long-term outcomes for both mothers and babies in this high-risk population.
Why it matters
Potential benefit: If successful, the program could lower gestational diabetes rates and subsequent risk of type 2 diabetes for mothers, with downstream benefits for child health.
How similar studies have gone: Prior pilot data showed a clinically meaningful reduction in GDM with the STRONG program, justifying a fully powered trial.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Hawley, Nicola — Yale University
- Study coordinator: Hawley, Nicola
Related research
Other NIH-funded projects on the same topics.
-
Digital twins of the hypothalamus, placenta, and gut to help manage gestational diabetes
A study using computer-based models of a pregnant person’s brain, placenta, and gut to better understand how gestational diabetes develops and how to tailor treatments.
-
IGF factors and binding proteins in gestational diabetes and fetal growth
A study in pregnant people looks at how insulin-like growth factors and their binding proteins affect gestational diabetes and how a baby grows.
-
Pancreatic beta cells, oxidative stress, and gestational diabetes
A study is exploring how oxidative stress and changes in pancreatic beta cells during pregnancy may contribute to gestational diabetes and future diabetes risk for both mother and baby.
-
NDPP-MAP: A tailored online-hybrid program to reduce long-term health risks after pregnancy with gestational diabetes
A patient-friendly program adapts a proven diabetes prevention approach to help women who had gestational diabetes lower their risk of type 2 diabetes and heart problems.
-
In Vivo Look at Placental Blood Flow in Gestational Diabetes
A non-invasive MRI study in pregnant people with gestational diabetes and those without will map how placental blood vessels work and relate to baby outcomes.
-
Metformin use in gestational diabetes and its effects on child health
A long-term study will follow children whose mothers were treated with metformin during gestational diabetes to see how it may affect their health as they grow.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.